Publications analysing pharmaceutical company actions for improving access to medicine and vaccines

The Access to Medicine Foundation publishes pharma company rankings as well as thematic studies focused on specific access-to-medicine priorities. These publications benchmark individual pharma and vaccine companies against their peers, and identify best practices and progress gaps on a range of access topics.

2016 Access To Medicine Index

2016 Access to Medicine Index

2014 ranking of the top 20 pharmaceutical companies based on their access-to-medicine performances for high-burden diseases in low- and middle-income countries.
Continue reading
2015 Methodology For The 2017 Access To Vaccines Index

2015 Methodology for the 2017 Access to Vaccines Index

The methodology comprises the first set of metrics for mapping the contributions of vaccine companies in improving access to vaccines. The 2017 Access to Medicine Index will be published early in 2017.
Continue reading
Access To Hepatitis C Treatment: How Are Pharma Companies Improving Access To Essential Treatments?

Access to hepatitis C treatment: How are pharma companies improving access to essential treatments?

The first systematic overview of the policies and practices put in place by pharmaceutical companies to address the accessibility of their hepatitis C treatments. The study analyses data submitted to the 2014 Access to Medicine Index.
Continue reading
2015 Methodology For The 2016 Access To Medicine Index

2015 Methodology for the 2016 Access to Medicine Index

Report describing the methodology for the 2016 Access to Medicine Index and how it was developed.
Continue reading
Rapid Access To Investigational Vaccines: An Analysis Of Access Provisions

Rapid access to investigational vaccines: an analysis of access provisions

An analysis of how large pharmaceutical companies are responding to the global need for accessible and affordable vaccines through access-oriented R&D. The study analyses data submitted to the 2014 Access to Medicine Index.
Continue reading
Access To Maternal Health: Pharmaceutical Companies’ Contribution To MDG 5

Access to Maternal Health: Pharmaceutical Companies’ Contribution to MDG 5

This landscape study analyses data submitted by pharmaceutical companies on maternal health and access to contraceptives for the 2014 Access to Medicine Index, supplemented by additional desk research.
Continue reading
2014 Access To Medicine Index

2014 Access to Medicine Index

2014 ranking of the top 20 pharmaceutical companies based on their access-to-medicine performances for high-burden diseases in low- and middle-income countries.
Continue reading
2013 Methodology For The 2014 Access To Medicine Index

2013 Methodology for the 2014 Access to Medicine Index

2013 Methodology for the 2014 Access to Medicine Index describes the methodology for the 2014 Access to Medicine Index and how it was developed.
Continue reading
2012 Access To Medicine Index

2012 Access to Medicine Index

2012 ranking of the top 20 pharmaceutical companies based on their access-to-medicine performances for high-burden diseases in low- and middle-income countries.
Continue reading
Longitudinal Analysis 2010-2012

Longitudinal Analysis 2010-2012

The study measures changes in company performance with regard to access to medicines and technologies for 33 relevant diseases in 103 low- and middle-income countries.
Continue reading
2012 Methodology Report – Stakeholder Review

2012 Methodology Report – Stakeholder Review

Monday, 16 January 2012. 2012 Methodology Report - Stakeholder Review describing the methodology for the 2012 Access to Medicine Index and how it was developed.
Continue reading
2010 Access To Medicine Index

2010 Access to Medicine Index

Monday, 7 June 2010. 2010 ranking of the top 20 pharmaceutical companies based on their access-to-medicine performances for high-burden diseases in low- and middle-income countries.
Continue reading
2010 Methodology & Stakeholder Review

2010 Methodology & Stakeholder Review

2010 Methodology & Stakeholder Review describing the methodology for the 2010 Access to Medicine Index and how it was developed.
Continue reading
2008 Access To Medicine Index

2008 Access to Medicine Index

Monday, 2 June 2008. 2008 ranking of the top 20 pharmaceutical companies based on their access-to-medicine performances for high-burden diseases in low- and middle-income countries.
Continue reading
2008 Access To Medicine Index Industry And Stakeholder Review

2008 Access to Medicine Index Industry and Stakeholder Review

Report describing the methodology for the 2008 Access to Medicine Index and how it was developed.
Continue reading

Sign up to receive updates about our work.